These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 1990536

  • 1. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients.
    Suciu-Foca N, Ho E, King DW, Yu YP, Yu-Kai S, Reed E, Cohen D, Brensilver JM, McCabe R, Rose E.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts.
    Reed E, Cohen DJ, Barr ML, Ho E, Marboe CC, Rose EA, Hardy M, Suciu-Foca N.
    Transplant Proc; 1992 Dec; 24(6):2494-5. PubMed ID: 1465842
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human erythropoietin decreases anti-HLA sensitization and may improve renal allograft outcome: involvement of anti-idiotypic antibody.
    Grimm PC, Sekiya NM, Robertson LS, Robinson BJ, Ettenger RB.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):407-8. PubMed ID: 1990568
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients.
    Reed E, Hardy M, Benvenisty A, Lattes C, Brensilver J, McCabe R, Reemstma K, King DW, Suciu-Foca N.
    N Engl J Med; 1987 Jun 04; 316(23):1450-5. PubMed ID: 3553951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody.
    Padányi A, Gyódi E, Rajczy K, Perner F, Petrányi GG.
    Clin Transplant; 1996 Oct 04; 10(5):455-60. PubMed ID: 8930462
    [Abstract] [Full Text] [Related]

  • 14. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A, Deka R, Bhowmik D, Dash SC, Tiwari SC, Guleria S, Mehta SN, Mehra NK.
    Clin Transplant; 2006 Oct 04; 20(1):85-90. PubMed ID: 16556160
    [Abstract] [Full Text] [Related]

  • 15. Specific HLA antibody production following renal transplantation.
    Martin S, Dyer PA, Gokal R, Mallick NP, Johnson RW.
    Transplant Proc; 1987 Feb 04; 19(1 Pt 1):898. PubMed ID: 3274885
    [No Abstract] [Full Text] [Related]

  • 16. Anti-idiotypic antibodies to HLA and their influence on patient sensitization.
    Reed E, Hardy M, Brensilver J, Lattes C, McCabe R, D'gati V, Reemtsma K, Suciu-Foca N.
    Transplant Proc; 1987 Feb 04; 19(1 Pt 1):762-3. PubMed ID: 3274865
    [No Abstract] [Full Text] [Related]

  • 17. Immunomodulation of kidney and heart transplants by anti-idiotypic antibodies.
    Hardy MA, Suciu-Foca N, Reed E, Benvenisty AI, Smith C, Rose E, Reemtsma K.
    Ann Surg; 1991 Oct 04; 214(4):522-8; discussion 528-30. PubMed ID: 1953103
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.
    Reinsmoen NL, Nelson K, Zeevi A.
    Transpl Immunol; 2004 Oct 04; 13(1):63-71. PubMed ID: 15203130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.